Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRB | P10828 | 1/20 | 0.53 |
| ▸ | TSHR | P16473 | 4/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.45 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.42 |
| ▸ | GLO1 | Q04760 | 1/20 | 0.42 |
| ▸ | MGAM | O43451 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | SI | P14410 | 1/20 | 0.41 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 2/20 | 0.38 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.38 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.36 |
| ▸ | CASP1 | P29466 | 1/20 | 0.36 |
| ▸ | SOAT1 | P35610 | 1/20 | 0.36 |
| ▸ | EGLN1 | Q9GZT9 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28342228 | 0.92 | ALDH1A1 (0.56) | THRBTSHRALDH1A1LMNAHSD17B10 | |
| SCHEMBL27832581 | 0.92 | ALDH1A1 (0.56) | THRBTSHRALDH1A1LMNAHSD17B10 | |
| Methacrylic Acid SCHEMBL27790083 | 0.92 | THRB (0.47) | THRBTSHRALDH1A1LMNAHSD17B10 | |
| Methylene Chloride SCHEMBL28244287 | 0.91 | THRB (0.57) | THRBTSHRALDH1A1LMNAHSD17B10 | |
| Chloromethane SCHEMBL17453350 | 0.89 | THRB (0.59) | THRBTSHRALDH1A1LMNAHSD17B10 | |
| Hydrogen Sulfide SCHEMBL11505632 | 0.89 | THRB (0.59) | THRBTSHRALDH1A1LMNAHSD17B10 | |
| SCHEMBL19409375 | 0.89 | THRB (0.64) | THRBTSHRALDH1A1LMNAHSD17B10 | |
| SCHEMBL15030 | 0.89 | — | — | |
| SCHEMBL16429830 | 0.87 | THRB (0.53) | THRBTSHRALDH1A1LMNAHSD17B10 | |
| Acetone SCHEMBL11325819 | 0.86 | THRB (0.61) | THRBTSHRALDH1A1LMNAHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 47 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-2124808-A | — | — | None | — | — | JP | disclosed |
| US-12636319-B2 | Pharmaceutical composition for preventing or treating atopic disease containing Akkermansia muciniphila strain | ENTEROBIOME INC. (KR) | 2026-05-26 | — | — | US | disclosed |
| US-12622934-B2 | Pharmaceutical composition for preventing or treating atopic disease containing Faecalibacterium prausnitzii strain | ENTEROBIOME INC. (KR) | 2026-05-12 | — | — | US | disclosed |
| EP-4698628-A1 | AKKERMANSIA BIWAENSIS FOR PREVENTING OR TREATING METABOLIC DISORDERS AND USESE THEREOF | ENTEROBIOME INC. (KR) | 2026-02-25 | — | — | EP | disclosed |
| US-20250099511-A1 | PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CANCER | ENTEROBIOME INC. (KR) | 2025-03-27 | — | — | US | disclosed |
| US-20250090534-A1 | Phosphodiesterase-5 Inhibitor Combinations, Methods of Making, and Methods of Use Thereof | VK RESEARCH ASSOCIATES INC. | 2025-03-20 | — | — | US | disclosed |
| US-20250057893-A1 | PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CANCER OR INFLAMMATORY DISEASE | ENTEROBIOME INC. (KR) | 2025-02-20 | — | — | US | disclosed |
| EP-4484581-A2 | AKKERMANSIA MUCINIPHILA EB-AMDK19 STRAIN AND USE THEREOF | ENTEROBIOME INC. (KR) | 2025-01-01 | — | — | EP | disclosed |
| US-20240390429-A1 | METHOD AND FORMULATION FOR TREATING RESPIRATORY DISEASES | ENTEROBIOME INC. (KR) | 2024-11-28 | — | — | US | disclosed |
| WO-2024205307-A1 | PHARMACEUTICAL COMPOSITION CONTAINING AZILSARTAN FOR TREATING HYPERTENSION | ㈜셀트리온 | 2024-10-03 | — | — | WO | disclosed |
| US-20220119445-A1 | SYNTHETIC CYCLIC PEPTIDES AND METHODS OF PREPARATION AND USE THEREOF | NATIONAL SCIENCE FOUNDATION | 2022-04-21 | — | — | US | disclosed |
| WO-2022076470-A1 | ORAL DELAYED BURST FORMULATION OF LOW-DOSE NALTREXONE OR NALOXONE USED FOR|TREATING FIBROMYALGIA AND LONG COVID | SORRENTO THERAPEUTICS, INC. (US) | 2022-04-14 | — | — | WO | disclosed |
| EP-3980039-A1 | PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING ATOPIC DISEASE CONTAININGAKKERMANSIA MUCINIPHILA | ENTEROBIOME INC. (KR) | 2022-04-13 | — | — | EP | disclosed |
| WO-2022045501-A1 | PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING ATOPIC DISEASE CONTAINING AKKERMANSIA MUCINIPHILA STRAIN | ENTEROBIOME INC. (KR) | 2022-03-03 | — | — | WO | disclosed |
| WO-2022045502-A1 | PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING ATOPIC DISEASE CONTAINING FAECALIBACTERIUM PRAUSNITZII STRAIN | ENTEROBIOME INC. (KR) | 2022-03-03 | — | — | WO | disclosed |
| WO-2021080184-A1 | SMALL-SIZED, SUSTAINED RELEASE PHARMACEUTICAL COMPOSITION COMPRISING CHOLINE ALFOSCERATE | 한국유나이티드제약 주식회사 | 2021-04-29 | — | — | WO | disclosed |
| CN-101528237-A | Elvucitabine pharmaceutical compositions | ACHILLION PHARMACEUTICALS INC (US) | 2009-09-09 | — | — | CN | disclosed |
| US-20080058733-A1 | ANTIBIOTIC(S)-POLYMER COMBINATION | HERAEUS KULZER GMBH & CO. KG (DE) | 2008-03-06 | — | — | US | disclosed |
| US-20020150549-A1 | Antibiotic(s)-polymer combination | HERAUES KULZER GMBH & CO.KG (DE) | 2002-10-17 | — | — | US | disclosed |
| JP-H02124808-A | DENTURE-BACKING AGENT | KOBAYASHI PHARMACEUT CO LTD | 1990-05-14 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12622934-B2 | Pharmaceutical composition for preventing or treating atopic disease containing Faecalibacterium prausnitzii strain | TSLP, KLK5, KLK14 | THRB 3595/4885TSHR 4359/4885ALDH1A1 3042/4885 |
| US-20220119445-A1 | SYNTHETIC CYCLIC PEPTIDES AND METHODS OF PREPARATION AND USE THEREOF | VIP, PTMS, IAPP | THRB 3085/4885TSHR 2949/4885ALDH1A1 4861/4885 |
| US-12636319-B2 | Pharmaceutical composition for preventing or treating atopic disease containing Akkermansia muciniphila strain | KLKB1, TSLP, AK1 | THRB 1688/4885TSHR 2438/4885ALDH1A1 730/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.